Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin addition to Sitagliptin in Japanese T2DM
NCT01545388Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Feb 2012
- Primary completion
- Mar 2013
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of liquid metformin (Aspargo Labs) in type 2 diabetes mellitus (T2DM), sponsored by Merck & Co.. Started Feb 2012; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01545388.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01545388.